Singapore markets open in 7 hours 15 minutes

Eli Lilly and Co (LLY.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
752.10+14.60 (+1.98%)
As of 07:22PM CEST. Market open.
Full screen
Previous close737.50
Open740.50
Bid752.10 x 100000
Ask753.70 x 100000
Day's range740.50 - 753.90
52-week range387.60 - 753.90
Volume206
Avg. volume369
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Insider Monkey

    Is Eli Lilly and Company the Largest Publicly Traded Healthcare Company?

    In this article, we will be taking a look at is Eli Lilly and Company the largest publicly traded healthcare company? If you wish to learn about more companies, head straight to the Top 20 Largest Publicly Traded Healthcare Companies. Major Players Driving the U.S. Healthcare Industry’s Growth and Innovation The global healthcare industry is […]

  • Barrons.com

    Hims & Hers Is Selling Copycat Weight-Loss Drugs. Here’s How.

    A plan by Hims & Hers Health to sell legal copies of Novo Nordisk weight loss drug Wegovy is drawing pushback from the industry, and bringing new attention to an area of concern for public-health officials. Enormous demand has created shortages of Novo’s Wegovy, as well as a competing weight loss injection from Eli Lilly called Zepbound. Both companies are spending billions of dollars to increase their manufacturing capacity, but the availability of the medicines is limited in the U.S., according to the Food and Drug Administration.

  • Benzinga

    Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety Concerns

    Australia announced on Wednesday that it would ban compounded versions of weight-loss drugs like Novo Nordisk A/S’s (NYSE:NVO) Ozempic and Eli Lilly And Co’s (NYSE:LLY) Mounjaro, citing safety concerns. Recently, the Chinese regulatory authority approved Eli Lilly’s diabetes drug, tirzepatide. Health Minister Mark Butler emphasized that these unregulated copies have not undergone rigorous testing, leading to potential patient risks. Related: The Ozempic Diet: Nestle Launches $5 Pizza For Weight